Clinical Trial Update: Phase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Futuximab/Modotuximab in combination with trifluridine/tipiracil versus trifluridine/tipiracil alone in previously treated metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Futuximab (futuximab)
• Modotuximab (modotuximab)
• trifluridine/tipiracil (trifluridine/tipiracil)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: TERMINATED | Results posted: 2024-03-05